Topical pharmaceutical containing heparin and method of treatment
OwnerRajko D. Medenicainventor
Life of this patent
Estimating the term…
Abstract
A topical pharmaceutical for the treatment of thrombosis or hematoma, and a method for the topical treatment of thrombosis or hematoma, are described. The topical pharmaceutical contains effective thrombosis-inhibiting amounts of heparin, allantoin, thymol, and mefenamic acid dispersed in a pharmaceutically-acceptable carrier for topical administration. The method of treating thrombosis and hematoma includes externally contacting the area with an effective amount of a composition containing heparin, allantoin, thymol, and mefenamic acid.
Claims21
A topical pharmaceutical composition effective for the treatment of thrombosis or hematomas comprising a therapeutically effective amount of each of heparin, allantoin, thymol, and mefenamic acid, dispersed in a pharmaceutically-acceptable carrier.
A topical pharmaceutical composition effective for the treatment of thrombosis, hematomas of any etiology, including post-traumatic hematoma and post-cytopenia hematoma, chronic venestasia, and diffuse hematoma patches comprising:
- from about 100 to about 300 I.U. heparin per gram total weight;
- from about 0.1 to about 3.0 weight percent allantoin;
- from about 0.1 to about 1.0 weight percent thymol;
- and
- from about 1.0 to about 5.0 weight percent mefenamic acid, dispersed in a pharmaceutically-acceptable carrier.
A method of topically treating an area affected by thrombosis or hematomas in a patient in need thereof comprising:
- externally contacting the area with an effective amount of a composition comprising a therapeutically effective amount of each of heparin, allantoin, thymol, and mefenamic acid, dispersed in a pharmaceutically-acceptable carrier.
Dependencies are inferred from the claim text.